PCG Membership
Member Institutions
3601 W. 13 Mile Rd., Royal Oak, MI 48073
California Protons Cancer Therapy Center
9730 Summers Ridge Rd, San Diego, CA 92121
Delray Medical Center
5352 Linton Boulevard, Delray Beach, FL 33484
Hampton University Proton Therapy Institute
40 Enterprise Parkway, Hampton, VA 23666
Inova Health Proton Center
8081 Innovation Park Dr., Fairfax, VA 22031
850 West Baltimore Street, Baltimore, MD 21201
200 First Street SW, Rochester, MN 55905
5777 East Mayo Boulevard, Phoenix, AZ, 85054
Miami Cancer Institute
8900 North Kendall Drive, Miami, FL 33176
New York Proton Center
225 East 126th Street, New York, NY 10035
Northwestern Medicine Proton Center
4455 Weaver Parkway, Warrenville, IL 60555
Procure Proton Therapy Center – New Jersey
103 Cedar Grove Lane, Somerset, New Jersey 08873
Oklahoma Proton Center – Oklahoma City
5901 W Memorial Road, Oklahoma City, OK 73142
Seattle Cancer Care Alliance Proton Therapy Center
1570 N 115th Street, Seattle, WA 98133
The University of Alabama at Birmingham (UAB)
1720 2nd Ave South, Birmingham, AL 35294
The University of Florida Proton Therapy Institute
2015 North Jefferson Street, Jacksonville, FL 32206
Willis-Knighton Proton Therapy Center
2600 Kings Highway, Shreveport, LA 71103
Membership Information
Full Membership:
Full membership with PCG includes access to the PCG registry (REG001-09) as well as ALL of the PCG trials/protocols listed here.
REGISTRY
PCG – REG001-09
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy
BREAST
PCG – BRE007-12
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
PCG – BRE008-12 (Closed to enrollment)
Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Patients with Stage II/III, Loco-Regional, Non-Metastatic Breast Cancer Requiring Whole Breast or Chest Wall Irradiation with Lymph Node Irradiation
LUNG
PCG – LUN005-12 (Closed to enrollment)
A Phase I/II Study of Hypo-fractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
PROSTATE
PCG – GU002-10
A Phase III Prospective Randomized Trial of Standard-fractionation vs. Hypo-fractionation with Proton Radiation Therapy for Low Risk Adenocarcinoma of the Prostate
PCG – GU003-10
Phase III Study of Mildly Hypo-fractionated Image Guided Proton Beam Radiation Therapy with or without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate
PCG – GU010-18
Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy
PANCREAS
PCG – PAN009-18
A Phase III Trial of Escalated Dose Proton Radiotherapy with Elective Nodal Irradiation and Concomitant Chemotherapy for Patients with Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma
Registry Membership:
A Registry membership with PCG includes access to the PCG registry (REG001-09) only.
REGISTRY
PCG – REG001-09
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy
Single Study Membership:
PCG offers membership on a per trial/protocol basis. Sites may choose to participate in any combination of the PCG trials/protocols listed below (the registry trial is excluded from this type of membership level).
BREAST
PCG – BRE007-12
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
PCG – BRE008-12 (Closed to enrollment)
Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Patients with Stage II/III, Loco-Regional, Non-Metastatic Breast Cancer Requiring Whole Breast or Chest Wall Irradiation with Lymph Node Irradiation
LUNG
PCG – LUN005-12 (Closed to enrollment)
A Phase I/II Study of Hypo-fractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
PROSTATE
PCG – GU002-10
A Phase III Prospective Randomized Trial of Standard-fractionation vs. Hypo-fractionation with Proton Radiation Therapy for Low Risk Adenocarcinoma of the Prostate
PCG – GU003-10
Phase III Study of Mildly Hypo-fractionated Image Guided Proton Beam Radiation Therapy with or without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate
PCG – GU010-18
Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy
PANCREAS
PCG – PAN009-18
A Phase III Trial of Escalated Dose Proton Radiotherapy with Elective Nodal Irradiation and Concomitant Chemotherapy for Patients with Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma
